2021 Armed Forces Annual District Meeting

Service in Changing Times

Speaker Biographies

Raquel Bono, MD, VADM, MC, USN (Ret)

Commissioned in the US Navy in June 1979, Raquel Bono obtained her baccalaureate degree from the University of Texas at Austin and attended medical school at Texas Tech University. She completed a surgical internship and a General Surgery residency at the Naval Medical Center Portsmouth, and a Trauma and Critical Care fellowship at the Eastern Virginia Graduate School of Medicine in Norfolk. Shortly after training, Bono saw duty in Operations Desert Shield and Desert Storm as head, Casualty Receiving, Fleet Hospital 5 in Saudi Arabia. Her various clinical leadership appointments included division head of Trauma; head of the Ambulatory Procedures Department; chair of the Laboratory Animal Care and Use Committee; and chair of the Medical Records Committee. As a senior military officer, Bono held a number of executive leadership positions at the National Naval Medical Center in Bethesda, Maryland; Navy Bureau of Medicine and Surgery; U.S. Pacific Command, Hawaii; Walter Reed National Military Medical Center; and culminating in the director, Defense Health Agency and Vice Admiral, US Navy.

Bono is a diplomat of the American Board of Surgery and has an Executive MBA from the Carson College of Business at Washington State University. She has been recognized by Modern Healthcare as one of the 50 Most Influential Clinical Executive Leaders (2019) and one of the 50 Most Influential Healthcare Physician Executives and Leaders (2018).

Warner K. Huh, MD

Warner K. Huh, MD is Chair of the Department of Obstetrics and Gynecology and holds the Margaret Cameron Spain Endowed Chair in the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham (UAB). He is also Professor in the Department of Surgery and Professor in the Department of Epidemiology in the UAB School of Public Health. His research interests include screening and prevention of HPV related diseases as well as novel immunotherapeutic approaches for pre-invasive disease of the cervix as well as cervical cancer. He serves as co-PI of the Johns Hopkins-UAB-University of Colorado Cervical Cancer Specialized Programs of Research Excellence (SPORE) program. He recently served as President of the ASCCP. He served on the steering committee for the ASCCP treatment guidelines and was co-chair of the ASCCP colposcopy standards effort. Dr. Huh has also served on the Board of Directors for the Society of Gynecologic Oncology (SGO) and is Past President of the SGO and ASCCP.

Brian Lein, MD, MG, MC, USA (Ret)

Brian C. Lein, MD is the Defense Health Agency (DHA) Assistant Director, Healthcare Administration. Dr. Lein provides leadership in the administration and management of health care delivery across all DoD hospitals and clinics, and the sustainment of the medical readiness of the armed forces and the readiness of the medical force within a unified Military Health System.

As Assistant Director, Health Care Administration, he assists the DHA director in the planning, direction and management of health care facilities, implementing policy, procedures and direction that affect health care delivery and administration, as well as provide cross-functional support to the markets and managing the TRICARE Health Plan.

Prior to joining DHA, Dr Lein served 30 years in the U.S. Army as a physician and leader, retiring as a major general and the Chief of the Army Medical Corps.

He has commanded at multiple levels, including the Army Medical Department Center and School, U.S. Army Medical Research and Materiel Command, and Landstuhl Regional Medical Center. Other leadership roles include the Deputy Army Surgeon General, Deputy Commanding General for Operations, U.S. Army Medical Command, theater surgeon in Afghanistan (ISAF), and command surgeon for US Army Forces Command CFLCC/Third Army, and 4th Infantry Division.  

He most recently served as a volunteer with the National Coronavirus Task Force as Serology Testing lead. Prior to this position, he worked at Hospital Corporation of America as Division Vice President for Graduate Medical Education.

Dr. Lein received his Bachelor of Science Degree from The United States Military Academy and his M.D. from Temple University School of Medicine, is board certified in General Surgery and a Fellow, American College of Surgeons. He received his Master’s in Strategic Studies from The U.S. Army War College.  

Antoinette Marengo-Barbick, MD

Dr. Marengo became the Chief Medical Officer at Planned Parenthood of the Pacific Southwest, home-based in San Diego, California, in 2018. Prior to working with Planned Parenthood, Dr. Marengo was the Associate Residency Program Director and Director of Family Planning at Naval Medical Center San Diego. She was the co-founder of the "PINC" clinic (walk-in contraception clinic) at Balboa, which has now been replicated at over 20 MTFs both CONUS and OCONUS. Dr. Marengo is prior active duty in the United States Navy and served her staff tour in 29 Palms, California from 2004-2007. Dr. Marengo is very active in ACOG and currently serves on the District IX executive team as the district secretary.

James Brian Szender, MD, MPH

Dr. J. Brian Szender is a gynecologic oncologist in practice with the START Center, treating women with cancer of the reproductive system. Dr. Szender received both a B.S. and M.S. in Biomedical Engineering from Boston University. He completed medical school at Creighton University in Omaha, Nebraska and then attended the University of Texas Health Science Center at San Antonio for his residency in Obstetrics & Gynecology. While he was a resident, Dr. Szender was recognized as the only two time winner of ACOG’s Donald F. Richardson Memorial Prize Paper.

Dr. Szender left Texas to complete his fellowship training in Gynecologic Oncology at the Roswell Park Cancer Institute in Buffalo, N.Y. During his time in Buffalo, Dr. Szender was trained in gynecologic cancer surgery, including management of disease in the upper abdomen, as well as prescribing patients with chemotherapy, targeted therapy, hormonal therapy, and immunotherapy. Dr. Szender also earned a Master of Public Health (MPH) from the State University of New York (SUNY) at Buffalo, with a concentration in epidemiology, and he helped manage patients on multiple clinical trials. With the breadth of education and experience Dr. Szender gained in his fellowship, he participated in numerous research projects with a particular interest in surgical quality improvement and novel therapeutic options for patients.

In 2017, Dr. Szender joined the START Center for Cancer Care. His practice encompasses the full spectrum of gynecologic cancer care, including minimally invasive and robotic surgery, upper abdominal surgery, prescription of chemotherapy, targeted therapy, hormonal therapy, and immunotherapy, as well as participation in clinical trials. Dr. Szender is a Fellow of the American Congress of Obstetricians and Gynecologists and has served nationally as a member of both the Wellness and the Policy, Quality, and Outcomes task forces with the Society of Gynecologic Oncology. Locally, he mentors medical and pre-medical students from local universities.

Arthur Jason Vaught, MD

Arthur Jason Vaught, MD, is an Assistant Professor of Gynecology and Obstetrics and Surgery at the Johns Hopkins University and Health Systems.  He also serves as the Medical Director of Labor and Delivery at the Johns Hopkins Main Campus in East Baltimore, MD. As a maternal fetal medicine specialist and surgical critical care physician Dr. Vaught is nationally known expert Obstetric Critical Care, Hypertensive Disorders of Pregnancy, as well as Cardio-Obstetrics. As Medical Director of Labor and Delivery, 20% of his time is spent in the organizational and clinical practices of the complex medical environment that is Labor and Delivery. His clinical time is spent managing high risk obstetric patients on the most extreme end of maternal medicine, which includes, but is not limited to, severe hypertensive disorders in pregnancy (severe chronic hypertension, preterm preeclampsia, and HELLP syndrome, severe valvular diseases in pregnancy, pulmonary hypertension, and hematologic disorders in pregnancy.

Dr. Vaught is also active in educational and leadership activities for the Society of Maternal Fetal Medicine, the Society of Critical Care Medicine, and the American Heart Association on a national level. His research is committed to studying hypertensive diseases of pregnancy such as preeclampsia, cardiac disease in pregnancy, postpartum hemorrhage, placenta accreta spectrum, and other risk factors and diseases state that increase maternal mortality and severe maternal morbidity. Dr. Vaught is poised to be assist in the implementation and success of this project.